ArticleJournal of neuro-oncology2016

Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats.

I A Netland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.